{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Exela%20Pharma%20Sciences%20LLC","name":"Exela Pharma Sciences LLC","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-05T10:06:05.086Z"},"count":1,"matches":[{"id":"2331cfaf31aabf04","posted_date":"2021-04-27","letter_issue_date":"2021-04-08","company_name":"Exela Pharma Sciences LLC","issuing_office":"Office of Pharmaceutical Quality Operations, Division II","subject":"Unapproved New Drug/Compounding/Misbranding","canonical_url":"https://api.morvs.ai/fda-warning/2331cfaf31aabf04"}]}